Crossmark

A qualitative study of cancer clinical trial network consumers’ acceptability of the modular approach to patient-reported outcome measurement: how much of it is “common sense”?

Crossref DOI link: https://doi.org/10.1186/s41687-026-01045-w

Published Online: 2026-03-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ng, Carrie-Anne https://orcid.org/0000-0001-9326-8492
Sousa, Mariana

Patterson, Tiffany

Mulhern, Brendan

Luckett, Tim
Funding

Funding for this research was provided by:

University of Technology Sydney
License Information

Text and Data Mining valid from 2026-03-25

Version of Record valid from 2026-05-04
More Information

Article History

Received: 3 July 2025

Accepted: 13 March 2026

First Online: 25 March 2026

Declarations

:

: The University of Technology Sydney Human Research Ethics Committee (ETH21-6090) reviewed and approved this study. All participants gave informed verbal consent.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below